Frey Rebeccainsider trades

In SEC Form 4 filings, Frey Rebecca is listed as Chief Executive Officer of Yarrow Bioscience, Inc. (YARW). Frey Rebecca reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 30.

Companies and roles

Company	Role	Transactions	Last filed
YARWYarrow Bioscience, Inc.	Chief Executive Officer	1	Oct 30

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-30

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
YARWYarrow Bioscience, Inc.	Oct 29	Oct 30	A · derivative	465,857	$20.00	$9,317,140	465,857	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.